Use Able AI chat for product recommendations

HRAS Polyclonal antibody

HRAS Polyclonal Antibody for WB, IHC, IP, ELISA

Host / Isotype

Rabbit / IgG

Reactivity

human, mouse, rat

Applications

WB, IHC, IP, ELISA

GTPase HRas, H RASIDX, HRAS1, C BAS/HAS, C H RAS

Formulation:  PBS, Azide, Glycerol
PBS, Azide, Glycerol
Conjugate:  Unconjugated
Unconjugated
Size/Concentration: 
SKU: 

-/ -

Freight/Packing: -

Quantity

Please visit your regions distributor:

Able AI
Able AI
What's the best dilution for HRAS in ?

Tested Applications

Positive WB detected inHeLa cells, MCF-7 cells, PC-12 cells, mouse kidney tissue, rat kidney tissue
Positive IP detected inHeLa cells
Positive IHC detected inhuman stomach tissue, mouse intestine
Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0

Recommended dilution

ApplicationDilution
Western Blot (WB)WB : 1:500-1:2000
Immunoprecipitation (IP)IP : 0.5-4.0 ug for 1.0-3.0 mg of total protein lysate
Immunohistochemistry (IHC)IHC : 1:50-1:500
It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, Check data in validation data gallery.

Product Information

15531-1-AP targets HRAS in WB, IHC, IP, ELISA applications and shows reactivity with human, mouse, rat samples.

Tested Reactivity human, mouse, rat
Cited Reactivityhuman
Host / Isotype Rabbit / IgG
Class Polyclonal
Type Antibody
Immunogen

CatNo: Ag7704

Product name: Recombinant human HRAS protein

Source: e coli.-derived, PGEX-4T

Tag: GST

Domain: 1-170 aa of BC006499

Sequence: MTEYKLVVVGAGGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHQYREQIKRVKDSDDVPMVLVGNKCDLAARTVESRQAQDLARSYGIPYIETSAKTRQGSRSGSSSSSGTLWDPPGPM

Predict reactive species
Full Name v-Ha-ras Harvey rat sarcoma viral oncogene homolog
Calculated Molecular Weight 21 kDa
Observed Molecular Weight 21 kDa
GenBank Accession NumberBC006499
Gene Symbol HRAS
Gene ID (NCBI) 3265
RRIDAB_2878147
Conjugate Unconjugated
FormLiquid
Purification MethodAntigen affinity purification
UNIPROT IDP01112
Storage Buffer PBS with 0.02% sodium azide and 50% glycerol, pH 7.3.
Storage ConditionsStore at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA.

Background Information

HRAS belongs to the small GTPase superfamily and Ras family. RAS family proteins (KRAS4A, KRAS4B, NRAS and HRAS) function as GDP-GTP-regulated binary on-off switches, which regulate cytoplasmic signaling networks that control diverse normal cellular processes (PMID: 26985062). HRAS is Involved in the activation of Ras protein signal transduction (PMID: 22821884). As HRAS mutations are associated to activation of RAF/MEK/ERK signaling in different cancers (PMID: 25435214). HRAS is mostly altered in head and neck squamous cell carcinoma (HNSCC) (5-9%), salivary glands (15%), and bladder cancer (5-30%) (PMID: 35621690).

Protocols

Product Specific Protocols
IHC protocol for HRAS antibody 15531-1-APDownload protocol
IP protocol for HRAS antibody 15531-1-APDownload protocol
WB protocol for HRAS antibody 15531-1-APDownload protocol
Standard Protocols
Click here to view our Standard Protocols

Publications

What published studies show

The HRAS polyclonal antibody (Cat# 15531-1-AP) has 3 total citations. These appear in Oncogene, Molecular Medicine Reports, and Naunyn-Schmiedeberg's Archives of Pharmacology. The associated research fields include RAS signaling pathway inhibition, multiple myeloma cell proliferation and apoptosis, and colorectal cancer mechanisms. All three studies used the antibody for Western blot in human samples.

SpeciesApplicationTitle
humanWB

Oncogene

Inhibition and degradation of NRAS with a pan-NRAS monobody

Authors - Michael Whaby
humanWB

Mol Med Rep

Sirtuin 2 knockdown inhibits cell proliferation and RAS/ERK signaling, and promotes cell apoptosis and cell cycle arrest in multiple myeloma.

Authors - Tianling Ding
humanWB

Naunyn Schmiedebergs Arch Pharmacol

The potential mechanism of Neu5Gc inducing colorectal cancer based on network pharmacology and experimental validation

Authors - Li-Chao Zhang
Loading...
||
New chat

Able™

正在加载,请稍候...